While macro factors could have short-term cross-industry impact, overall, the underlying fundamentals in animal health remains strong, and Elanco remains well positioned to deliver in today's environment and over the long term. With this industry backdrop, we continue to expect 2% to 3% constant currency revenue growth for 2022. On Slide 6, while we have adjusted our guidance for continued strength in the U.S. dollar, the underlying revenue assumptions we shared in February remain largely intact.